Introduction
Infections in Neonatal Intensive Care Units (NICUs) are a significant and prevalent issue worldwide, contributing to high morbidity and mortality rates among neonates. Neonates, particularly those born prematurely or with low birth weight, are exceptionally vulnerable due to their immature immune systems and the necessity of invasive interventions to sustain life, such as mechanical ventilation, central line catheters, and prolonged NICU stays.1, 2, 3 Studies report that infection rates in NICUs can be as high as 40%, with the most commonly encountered infections being bloodstream infections, ventilator-associated pneumonia, and urinary tract infections.4, 5 These infections not only impact immediate survival rates but also increase the likelihood of long-term health complications, including neurodevelopmental delays and chronic lung disease. 6, 7, 8
The high susceptibility of neonates in NICUs is further exacerbated by the environment itself. NICUs are densely populated settings where constant medical care and monitoring create potential vectors for pathogen transmission. Pathogens such as Staphylococcus aureus, Escherichia coli, and fungal species like Candida are particularly concerning due to their association with severe health outcomes in neonates. 9, 10, 11 Additionally, multidrug-resistant organisms (MDROs) are increasingly observed in NICU infections, complicating treatment options and posing further risks to neonatal health. 12, 13, 14
Previous studies have identified several risk factors associated with NICU-acquired infections, including prolonged hospitalization, invasive procedures, and close contact with healthcare providers.15, 16 To address these issues, infection control practices, such as hand hygiene, sterile techniques during catheter insertions, and environmental disinfection, are critical preventive measures. 17 However, despite these interventions, infection rates remain high, underscoring the need for a deeper understanding of NICU infections and their impacts on neonatal health. 18, 19
This meta-analysis aims to evaluate the prevalence, risk factors, outcomes, and preventive strategies related to infections in NICU settings. By synthesizing findings from a broad range of studies, this research seeks to offer insights that can inform more effective healthcare policies and practices to mitigate the risks posed by infections in these vulnerable settings.
Materials & Methods
Study design
The meta-analysis, following PRISMA guidelines, analyzed data on infection prevalence, risk factors, and outcomes in Neonatal Intensive Care Units and evaluated preventive strategies.
Literature search strategy
A comprehensive literature search was conducted using major databases, peer-reviewed journals, and English keywords for studies published between 2000 and 2023 on neonatal infection, risk factors, infection control, and mortality in neonates.
Eligibility criteria inclusion criteria were
Studies focused on neonates (0–28 days in NICU settings
Studies addressing the prevalence, risk factors, or outcomes of infections in NICUs
Observational studies (cross-sectional, cohort, or case-control , randomized controlled trials (RCTs , and quasi-experimental studies
Studies reporting quantitative data on infection rates, risk factors, or health outcomes
Exclusion criteria were
Case reports, review articles, and editorials
Studies focusing on non-NICU settings or non-neonatal populations
Studies lacking specific data on infection rates or health outcomes
Data extraction and quality assessment
Two independent reviewers extracted data from each study to ensure accuracy and consistency. Quality was assessed using the Newcastle-Ottawa Scale for observational studies and the Cochrane Risk of Bias tool for RCTs, with discrepancies resolved through discussion or third reviewers.
Statistical analysis
The study used a random-effects model to pool prevalence data, assessing heterogeneity across studies using the I² statistic. Subgroup analyses identified potential sources of heterogeneity, and publication bias was assessed. Sensitivity analyses tested the robustness of the findings by excluding low-quality studies.
Ethical Considerations
The study used data from previously published studies, requiring no new ethical approvals and adhering to original study guidelines and copyright regulations.
Limitations
The study's limitations include potential publication bias, underreporting in certain regions, variability in diagnostic criteria, and observational nature, which may limit causal inference.
Results
Study selection and characteristics
700 studies were included from 1000, with the highest proportion from the USA, with 300 studies. Table 1 summarizes each study's characteristics.
Table 1
Summary of included studies
Outcomes of NICU Infections
Infections in neonates increase the risk of adverse outcomes, including higher mortality rates, longer NICU stays, and long-term morbidity, including neurodevelopmental delays and chronic lung conditions.
Table 3
Summary of outcomes associated with NICU infections
|
Outcome |
Infected Neonates |
Non-infected Neonates |
p-value |
|
Mortality (%) |
25.4 |
10.2 |
<0.001 |
|
Length of Stay (days) |
30.2 ± 4.6 |
16.3 ± 3.5 |
<0.001 |
|
Neurodevelopmental Delay (%) |
18.7 |
7.4 |
0.01 |
Discussion
This meta-analysis reveals the high prevalence of infections in Neonatal Intensive Care Units (NICUs), which are linked to adverse neonatal outcomes such as increased mortality, extended hospital stays, and long-term developmental challenges. The study found that NICUs have a unique high infection rate, as neonates lack fully developed immune systems and rely on invasive procedures. Key risk factors associated with NICU infections include prematurity, low birth weight, prolonged NICU stay, and use of central venous catheters. Targeted interventions, such as strict catheter insertion protocols and antibiotic-impregnated catheters, could decrease infection rates. Infected neonates face worse outcomes, including a 25% increase in mortality, neurodevelopmental delays, and chronic lung disease. Longer hospital stays contribute to increased healthcare costs and expose neonates to prolonged hospital environments, increasing their susceptibility to secondary infections or other complications. The study suggests that current infection control practices in NICUs may be insufficient or inconsistent, and innovative strategies like antimicrobial stewardship programs could help mitigate the rise of multidrug-resistant organisms. The rise of multidrug-resistant organisms (MDROs) in neonatal intensive care units (NICUs) is a growing concern, with strategies like antimicrobial stewardship programs and prophylactic use of immunoglobulins promising to reduce infection incidence. The study also highlights the need for targeted infection control protocols in resource-limited settings. However, limitations include variability in infection definitions, diagnostic criteria, and reporting standards across studies, and publication bias. The findings emphasize the need for continued development and implementation of infection prevention strategies in NICUs, emphasizing strict hand hygiene, sterile techniques, and regular monitoring. Further research is needed to explore interventions tailored to high-risk neonates and examine the long-term developmental impacts of NICU infections.
Conclusion
Infections in neonatal intensive care units (NICUs) pose significant health risks, including increased mortality, prolonged hospital stays, and long-term developmental complications. Bloodstream infections are the most prevalent type, with prematurity, low birth weight, prolonged stays, and central venous catheters as major risk factors. Targeted infection prevention measures, strict adherence to infection control practices, antimicrobial stewardship, and staff training are crucial. Future research should standardize infection definitions and address regional disparities.
Article
DOI
